Bottom line
What is PABVX's expense ratio?
PABVX's expense ratio is 0.89%, or about $89 a year on every $10,000 invested. That is more expensive than 52% of mid-cap funds we track (median 0.88%). It has no front-end sales load.
Updated Feb 27, 2026
PABVX fee table
| Net expense ratio | 0.89% |
|---|---|
| Gross expense ratio | 0.91% |
| Management fee | 0.65% |
| Other expenses | 0.26% |
| Fee waiver / reimbursement | -0.02% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 27, 2026
What PABVX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PABVX | $91 | $288 | $502 | $1,118 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.89% expense ratio costs roughly $49,800 in lost growth, versus about $49,300 for the median mid-cap fund (0.88%).